Needles, Syringes, IV Access Market Research Reports & Industry Analysis
This issue has placed a premium on the development of new products designed to prevent accidental needle sticks, which spread blood-borne pathogens.
Medical supply manufacturers around the globe are trying to develop new safety and innovative products, including sharps safety medical devices to protect health care workers. The University of Virginia’s International Healthcare Worker Safety Center lists 12 companies offering retractable needles/syringes.
The products involve a variety of technologies, for example, a safety needle device has a needle encapsulation sleeve after it has been used; the sleeve automatically resheathes the needle and locks it so that it cannot be exposed.
Blunt safety devices deploy a two-needle system, one inside the other. The inside needle is hollow and has a flat, blunt end. The outside sharp needle is used to access the vein. The inner needle moves forward and past the sharp needle to insure safety before it is removed from the patient. Such devices are known as first-generation safety products.
The retractable syringe is a unique device requiring no change in the basic procedure of delivery of the medication by health care workers. Once the injection is complete, the needle safely retracts from the patient into the syringe barrel -- thus, there is no risk of accidental needle stick injuries that can transmit HIV, hepatitis, or other infections to health care workers. Retractable syringes are considered second generation safety products.
Needles, Syringes, IV Access Industry Research & Market Reports
-
Pipettes and Pipettors
... at a CAGR of 5.7% over the analysis period 2024-2030. Pipette Tips, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.5 Billion by the end of ... Read More
-
IV Tubing Sets & Accessories
... Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Primary IV Tubing Sets, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach ... Read More
-
Safety Needles
... CAGR of 6.9% over the analysis period 2024-2030. Active, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$3.2 Billion by the end of the analysis period. ... Read More
-
Hypodermic Needles
... CAGR of 3.9% over the analysis period 2024-2030. Safety Needles, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Dental Syringes
... CAGR of 6.2% over the analysis period 2024-2030. Non-Disposable Syringes, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$99.6 Million by the end of the analysis ... Read More
-
Injection Pens
... CAGR of 5.9% over the analysis period 2024-2030. Disposable, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$50.0 Billion by the end of the analysis period. ... Read More
-
Infusion Pumps
... CAGR of 4.7% over the analysis period 2024-2030. Volumetric Infusion Pumps, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Intravenous Immunoglobulin (IVIg)
... at a CAGR of 8.5% over the analysis period 2024-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$13.7 Billion by the end of the ... Read More
-
Patient-Controlled Analgesic Pumps
... at a CAGR of 5.2% over the analysis period 2024-2030. Electronic, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$455.6 Million by the end of the ... Read More
-
Needles
... 4.9% over the analysis period 2024-2030. Conventional Needles, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$6.6 Billion by the end of the analysis period. Growth ... Read More
-
Huber Needles
... CAGR of 4.8% over the analysis period 2024-2030. IV Cancer Treatment, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$45.7 Million by the end of the ... Read More
-
Amniocentesis Needles
... CAGR of 2.1% over the analysis period 2024-2030. 150 mm & Above, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end of ... Read More
-
Intravenous Equipment
... CAGR of 3.4% over the analysis period 2024-2030. IV Catheters, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$4.8 Billion by the end of the analysis ... Read More
-
Biopsy Needles
... CAGR of 5.7% over the analysis period 2024-2030. Vacuum-Assisted, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$971.8 Million by the end of the analysis period. ... Read More
-
Aspiration & Biopsy Needles
... 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Biopsy Needles, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.0 Billion by the ... Read More
-
Disinfection Caps
... CAGR of 4.2% over the analysis period 2024-2030. Non-Retail, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$289.3 Million by the end of the analysis period. ... Read More
-
Home Infusion Therapy
... at a CAGR of 6.7% over the analysis period 2024-2030. Infusion Pumps, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$29.4 Billion by the end of ... Read More
-
Acute Care Needleless Connectors
... 2030, growing at a CAGR of 9.1% over the analysis period 2024-2030. Simple Needleless Connectors, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$1.2 Billion by ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Special Purpose Needles
... at a CAGR of 6.7% over the analysis period 2024-2030. Hypodermic Needles, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$6.9 Billion by the end of ... Read More
-
Vaccine Delivery Devices
... at a CAGR of 4.4% over the analysis period 2024-2030. Syringes, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$5.3 Billion by the end of the ... Read More
-
Enteral Syringes
... CAGR of 5.6% over the analysis period 2024-2030. Disposable, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Syringes
... 6.8% over the analysis period 2024-2030. Prefilled Syringes, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$10.6 Billion by the end of the analysis period. Growth ... Read More
-
Pipette Tips
... CAGR of 5.1% over the analysis period 2024-2030. Manual, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$748.2 Million by the end of the analysis period. ... Read More
-
Intravenous (IV) Solutions
... at a CAGR of 7.5% over the analysis period 2024-2030. Parenteral Nutrition, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$15.1 Billion by the end of ... Read More
Research Assistance
